Publications by authors named "Desiree Davison"

Claim this Profile
C
Comprehensive Proteomics Metadata and Integrative Web Portals Facilitate Sharing and Integration of LINCS Multiomics Data.
Dušica Vidović, Behrouz Shamsaei, Stephan C Schürer, Phillip Kogan, Szymon Chojnacki, Desiree Davison

Mol Cell Proteomics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Comprehensive Proteomics Metadata and Integrative Web Portals Facilitate Sharing and Integration of LINCS Multiomics Data".
Dušica Vidović, Behrouz Shamsaei, Stephan C Schürer, Phillip Kogan, Szymon Chojnacki, Desiree Davison

Mol Cell Proteomics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors.
Nicholas D Camarda, Qing Lu, Dawn M Meola, Joshua J Man, Zeyuan Song, Desiree Davison

Clin Sci (Lond)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling dataset of chemical perturbations in multiple biological backgrounds.
Deborah O Dele-Oni, Karen E Christianson, Shawn B Egri, Alvaro Sebastian Vaca Jacome, Katherine C DeRuff, Desiree Davison

Sci Data· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cas9 activates the p53 pathway and selects for p53-inactivating mutations.
Oana M Enache, Veronica Rendo, Mai Abdusamad, Daniel Lam, Desiree Davison

Nat Genet· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations.
Oana M Enache, Veronica Rendo, Mai Abdusamad, Daniel Lam, Desiree Davison

Nat Genet· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML.
Srila Gopal, Qing Lu, Joshua J Man, Wendy Baur, Sitara P Rao, Desiree Davison

Blood Adv· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations.
Lev Litichevskiy, Ryan Peckner, Jennifer G Abelin, Jacob K Asiedu, Amanda L Creech, Desiree Davison

Cell Syst· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.
Aravind Subramanian, Rajiv Narayan, Steven M Corsello, David D Peck, Ted E Natoli, Desiree Davison

Cell· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes.
Jennifer G Abelin, Jinal Patel, Xiaodong Lu, Caitlin M Feeney, Lola Fagbami, Desiree Davison

Mol Cell Proteomics· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis